CTKB
#2796
Cytek Biosciences, Inc. - Common Stock
4.6 8 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.30%
Monthly Change
+6.85%
6 month change
+5.41%
Year Change
+14.15%
Previous Close
4.6 2
Open
4.6 8
Low
4.6 8
High
4.6 8
Volume
46
Financials
- Market Capitalization 608.32 M
- Employee 702
- Founded 1992
- CEO N/A
- Website www.cytekbio.com
- Headquarter Delaware, United States
- FIGI BBG00D36Q0Z7
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.7
Price to sales ratio
3.2
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2708 |  SSII SS Innovations International Inc. - Common Stock | 3.48 USD | +1.75% | -4.13% | -13.00% | -59.39% | 697.34 M USD | ||
| 2791 |  KIDS OrthoPediatrics Corp. - Common Stock | 23.65 USD | +1.42% | -7.80% | +19.20% | +38.87% | 617.50 M USD | ||
| 2847 |  DCTH Delcath Systems, Inc. - Common Stock | 16.34 USD | -0.31% | -4.50% | +40.50% | +58.03% | 566.98 M USD | ||
| 2853 |  BWAY BrainsWay Ltd - American Depositary Shares | 14.30 USD | -0.69% | -1.52% | -2.39% | -5.98% | 560.07 M USD |
Frequently asked questions about Cytek Biosciences, Inc. Common Stock
What is the Cytek Biosciences, Inc. Common Stock stock price today?
The current price of Cytek Biosciences, Inc. Common Stock (CTKB) is 4.68. Over the past 24 hours, the stock has changed by +1.30%. Follow the CTKB chart for real-time price dynamics.
What is the stock ticker of Cytek Biosciences, Inc. Common Stock?
Cytek Biosciences, Inc. Common Stock trades under the ticker CTKB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytek Biosciences, Inc. Common Stock stock going up?
CTKB has changed by -2.50% over the last week, +6.85% over the last month, and +14.15% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cytek Biosciences, Inc. Common Stock?
Cytek Biosciences, Inc. Common Stock currently has a market capitalization of 608.32 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cytek Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, Cytek Biosciences, Inc. Common Stock reported earnings of -0.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cytek Biosciences, Inc. Common Stock revenue for the last quarter?
Cytek Biosciences, Inc. Common Stock reported quarterly revenue of 48.14 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cytek Biosciences, Inc. Common Stock net income for the last quarter?
Cytek Biosciences, Inc. Common Stock reported net income of -12.16 M for the last quarter. The previous quarter showed -18.87 M, which means net income changed by +35.56%.
How many employees does Cytek Biosciences, Inc. Common Stock have?
As of the latest available data, Cytek Biosciences, Inc. Common Stock has 702 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytek Biosciences, Inc. Common Stock EBITDA?
Cytek Biosciences, Inc. Common Stock EBITDA is -9.39 M, and its EBITDA margin is -19.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytek Biosciences, Inc. Common Stock stock?
You can buy Cytek Biosciences, Inc. Common Stock (CTKB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytek Biosciences, Inc. Common Stock stock?
Investing in Cytek Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTKB chart and related analysis on metatrader.com as part of your research.